本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Akoya Biosciences, Inc.

1.29
+0.03002.38%
盤後1.300.0100+0.78%17:42 EDT
成交量:18.45萬
成交額:23.17萬
市值:6,433.93萬
市盈率:-1.34
高:1.30
開:1.26
低:1.22
收:1.26
資料載入中...
2025/06/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/21

重要事件披露

Form 8-K - Current report
2025/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/05/13

重要事件披露

Form 8-K - Current report
2025/05/12

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/29

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/04/29

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/04/28

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/04

重要事件披露

Form 8-K - Current report
2025/04/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/04/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/03/18

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/03/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations